BridgeBio Pharma, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BBIO Nasdaq 2830 bridgebio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BridgeBio Pharma, Inc.

BridgeBio Pharma (BBIO) Valuation After Attruby-Driven Earnings Beat and Renewed Analyst Support - Dec 12th, 2025 10:15 am
What Recent Clinical Wins Mean For BridgeBio Pharma’s Evolving Growth Story - Dec 12th, 2025 9:08 am
PayPal downgraded, Roku upgraded: Wall Street's top analyst calls - Dec 11th, 2025 7:39 am
Here Are Thursday’s Top Wall Street Analyst Research Calls: American Eagle Outfitters, Ferrari, Intuitive Surgical, Roku, PayPal, Synopsis, Visa, and More - Dec 11th, 2025 7:17 am
This Hot Biotech Stock Just Set New All-Time Highs - Dec 10th, 2025 10:00 am
How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint - Dec 2nd, 2025 6:00 am
BridgeBio Pharma Surges 170% as New Clinical Partnerships Spark Valuation Debate - Dec 2nd, 2025 3:10 am
Should You Grab This ‘Strong Buy’ Growth Stock With 56% Upside? - Dec 1st, 2025 5:30 am
BridgeBio (BBIO) Q3 2025 Earnings Call Transcript - Nov 27th, 2025 4:02 pm
BridgeBio to Participate in December Investor Conferences - Nov 25th, 2025 5:30 am
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Nov 19th, 2025 2:01 pm
BridgeBio Pharma (BBIO): Exploring Valuation After a 20% Share Price Surge - Nov 11th, 2025 11:15 pm
Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations - Nov 8th, 2025 8:41 am
National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry - Nov 7th, 2025 11:00 am
BridgeBio Pharma Inc (BBIO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising ... - Nov 4th, 2025 6:09 pm
BridgeBio to Participate in November Investor Conferences - Nov 4th, 2025 5:30 am
Are Shares of BridgeBio Pharma Still a Bargain After 146% Rally and Clinical Trial Buzz? - Nov 3rd, 2025 4:15 pm
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025 - Nov 3rd, 2025 5:30 am
Alnylam Stock Has Almost Doubled In 2025. But It Took A Hit On Earnings. - Oct 30th, 2025 2:15 pm
BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue Estimates - Oct 29th, 2025 3:15 pm